Related Experiment Video

Updated: May 4, 2026

Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

16.5K

Emerging drug delivery approach using nanomaterials for the treatment of endometrial cancer

Zhuorong Miao1, Xiaoyan Xiong2, Jiahong Gao1

  • 1Shenzhen Maternity and Child Healthcare Hospital, Women and Children's Medical Center, Southern Medical University, Shenzhen, Guangdong Province, China.

Frontiers in Medical Technology
|December 15, 2025
PubMed

Insights

Emerging nanomaterial drug delivery systems offer a promising new approach to enhance endometrial cancer treatment, overcoming limitations of conventional therapies. These advanced nanocarriers show potential for improved therapeutic efficiency in preclinical studies.

Area of Science:

  • Oncology
  • Nanomedicine
  • Drug Delivery

Background:

  • Endometrial cancer incidence and mortality are rising globally.
  • Conventional treatments for endometrial cancer have significant limitations, including toxicity and resistance.
  • Nanomaterials offer unique properties for advanced drug delivery.

Purpose of the Study:

  • To review emerging nanomaterial-based drug delivery approaches for endometrial cancer.
  • To analyze the synthesis, mechanisms, and preclinical efficacy of various nanocarriers.
  • To discuss challenges and future directions in nanomedicine for endometrial cancer.

Main Methods:

  • Classification of common therapeutic nanomaterials: polymer-based nanocarriers, quantum dots, liposomes, and exosomes.
  • Analysis of synthesis methods and drug delivery mechanisms.
  • Review of preclinical efficacy data for different nanocarrier systems.

Main Results:

  • Nanomaterials demonstrate potential for enhanced therapeutic efficiency in preclinical endometrial cancer models.
  • Various nanocarriers, including liposomes and exosomes, show promise in overcoming treatment challenges.
  • Preclinical data supports the efficacy of nanomedicine in combating endometrial cancer.

Conclusions:

  • Nanomaterial-based drug delivery represents a promising strategy to improve endometrial cancer treatment outcomes.
  • Further research is needed to address scientific challenges and translate preclinical findings.
  • Future perspectives involve optimizing nanocarrier design and clinical application for endometrial cancer therapy.
Keywords:
drug deliveryendometrial cancerfertility-preservation treatmentnanomaterialsnanoplatform

More Related Videos

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.4K
Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

6.4K

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
168